Codes / ICD10CM / H35.382

H35.382 Toxic maculopathy, left eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Toxic Maculopathy, Left Eye (H35.382)

Name of the Condition

  • Toxic Maculopathy, Left Eye

Summary

Toxic maculopathy is a condition affecting the macula, the central part of the retina responsible for sharp central vision. It results from exposure to substances that damage retinal tissue, potentially leading to vision impairment. When limited to the left eye, the condition may present with unilateral symptoms and requires targeted evaluation of the affected eye.

Causes

The condition is caused by exposure to toxic substances or medications that harm the macula. Common culprits include certain drugs (e.g., antimalarials, tamoxifen) and environmental toxins. The toxic effects disrupt retinal cells, leading to functional and structural changes in the left eye.

Risk Factors

  • Long-term use of medications known to affect the retina.
  • High cumulative doses of retinal-toxic drugs.
  • Pre-existing retinal conditions or genetic susceptibility.
  • Age-related changes in retinal metabolism.

Symptoms

  • Blurred or distorted central vision in the left eye.
  • Difficulty reading or seeing fine details with the left eye.
  • Changes in color perception in the left eye.
  • Dark spots or blind areas in the visual field of the left eye.

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing and dilated fundoscopy of the left eye. Optical coherence tomography (OCT) assesses retinal layers, while fluorescein angiography may detect vascular changes. A detailed patient history of medication or toxin exposure is critical for identifying the cause.

Treatment Options

Treatment focuses on discontinuing or substituting the offending agent, if possible. Regular monitoring of retinal health is essential. Vision rehabilitation, such as low-vision aids, may be recommended to manage symptoms. In some cases, antioxidant supplements or other supportive therapies may be considered.

Prognosis and Follow-Up

Prognosis depends on the extent of macular damage and the timeliness of intervention. Early identification and removal of the toxic agent can improve outcomes. Follow-up care includes periodic eye examinations to monitor for progression or recovery. Long-term monitoring is often necessary to assess visual stability.

Complications

Potential complications include permanent vision loss, difficulty with daily activities, and reduced quality of life. Severe cases may lead to irreversible macular damage, affecting central vision permanently.

Lifestyle & Prevention

Avoiding known retinal-toxic medications or substances is key to prevention. Patients should inform healthcare providers of any history of retinal issues before starting new treatments. Regular eye exams are recommended for those on long-term medications with retinal risks.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden changes in vision, such as blurriness, distortion, or blind spots in the left eye. Prompt evaluation is crucial to minimize potential damage and guide appropriate management.

Tips for Medical Coders

Document the laterality (left eye) clearly in the medical record. Ensure the diagnosis is supported by clinical findings, such as fundoscopic or OCT evidence of macular changes. Include details of toxin or medication exposure when available to justify the code assignment.

Book a walkthrough

H35.382 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.